LncRNA SNHG12 in extracellular vesicles derived from carcinoma-associated fibroblasts promotes cisplatin resistance in non-small cell lung cancer cells
Sign Up to like & getrecommendations! Published in 2022 at "Bioengineered"
DOI: 10.1080/21655979.2021.2018099
Abstract: ABSTRACT Non-small-cell lung cancer (NSCLC) is defined as the most universally diagnosed class of lung cancer. Cisplatin (DDP) is an effective drug for NSCLC, but tumors are prone to drug resistance. The current study set… read more here.
Keywords: xiap; nsclc cells; resistance; lncrna snhg12 ... See more keywords
LncRNA SNHG12 improves cerebral ischemic-reperfusion injury by activating SIRT1/FOXO3a pathway through inhibition of autophagy and oxidative stress.
Sign Up to like & getrecommendations! Published in 2020 at "Current neurovascular research"
DOI: 10.2174/1567202617666200727142019
Abstract: BACKGROUND Ischemia/reperfusion (I/R) injury involves complex biological processes and molecular mechanisms such as autophagy. Oxidative stress plays a critical role in the pathogenesis of I/R injury. LncRNAs are the regulatory factor of cerebral I/R injury.… read more here.
Keywords: sirt1 foxo3a; oxidative stress; autophagy oxidative; injury ... See more keywords